This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

President Barack Obama's Cannabis Industry Statements Mark Historical Support For The Cannabis Industry In A Recent Interview With Barbara Walters Of ABC News

DALLAS, Dec. 18, 2012 /PRNewswire/ -- X-Change Corp (NASDAQ OTC: XCHC), a U.S. boutique company whose niche is extract-based Cosmeceutical and Neutroceutical solutions through its Phytiva brand product line, is pleased with President Barack Obama's recent statements with regard to the newly-enacted laws in the States of Washington and Colorado, and the company views these statements as highly consequential for the future of its Phytiva line of products.  X-Change Corp interprets the President's position as a paradigmatic shift for the Cannabis industry, allowing for the creation of new markets and opportunities and adding strength to emerging medicinal, Cosmeceutical, and Neutroceutical sectors.

President Obama, in an interview with Barbara Walters of ABC News on December 13, 2012, stated, "It would not make sense for us to see a top priority as going after recreational users in states that have determined that it's legal."  Colorado Governor John Hickenlooper proclaimed Amendment 64 as amending the state constitution on December 10, 2012 just days after Washington State Initiative 502 formally became law, legalizing the recreational use of cannabis.

CNBC estimates that the Cannabis industry is a $40 Billion dollar a year business. Internal estimates illustrate the Cannabis industry is closer to $73 Billion a year, with some industry estimates placing it over $100 Billion.  There are now 18 states that have some type of legal Cannabis Program, along with several countries including Canada, the Czech Republic, and Israel.

Global political and business leaders have come out publicly in support of ending what billionaire Richard Branson has described as the war on drugs:  a "trillion dollar failure."  The James A Baker III Foundation voiced support to ending the war on drugs.  President Obama and Republican nominee Mitt Romney during the elections both made a statement in support of ending the war on drugs.  This past week Richard Branson's son, with his father's full support, released an anti-prohibition documentary narrated by Morgan Freeman entitled "Breaking The Taboo."  The YouTube release follows The Global Commission on Drug Policy's study of the U.S. war on drugs and includes 147 interviews with leaders around the world, concluding drug prohibition to be the "biggest failure of global policy in the last 40 years."

Robert J. Kane, President of X-Change Corp, said, "It is a privilege to be part of this historic time by leading a company with cannabinoid-based products from which the entire world should benefit going forward.  We continue, through our relationship with Cannabis Science, to develop products that have medicinal value, while at the same time using science and education to create products for the quickly-growing Cosmeceutical and Nutraceuticals markets."

About Phytiva

Phytiva is the newly relaunched brand that is a hybrid of a proven, existing product line that has been well-managed and conservatively-run for over a decade with a hemp-based product line, utilizing the unique and potent benefits of the hemp plant. Phytiva's revolutionary formulations target not just the symptom, but also the cause.  Hemp is the ideal basis for healing solutions and has been utilized for centuries, as skin responds extremely well to its properties.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,943.81 +28.74 0.17%
S&P 500 1,967.57 +2.89 0.15%
NASDAQ 4,415.49 +19.2860 0.44%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs